Form 4 for NGVT Ingevity Corp
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-01 · accession 0001653477-25-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-05 | 2025-05-01 | NGVT | Blackwell Jean | Dir | A - Grant | $0.00 | +4,057 | 6,857 | +145% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-01 | A | A | 4,057 | $0.00 | 6,857 | D | — | — | (F1) Grant of restricted stock units pursuant to Ingevity Corporation's 2016 Omnibus Incentive Plan, which will vest in full on May 1, 2026. (F2) Excludes 1,645 shares that were previously transferred by the reporting person to the Jean S. Blackwell Revocable Trust (the "Transferred Shares"). |